{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:58:12Z","timestamp":1793750292709,"version":"4.6.1"},"reference-count":205,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019418","name":"NIHR Maudsley Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"National Institute for Health Research Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ymthe.2025.09.011","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:05:25Z","timestamp":1757347525000},"page":"5945-5964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Immunology of RNA-based vaccines: The critical interplay between inflammation and expression"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8093-8741","authenticated-orcid":false,"given":"John S.","family":"Tregoning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranya","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Shattock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"DeRosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.09.011_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how\u2019s and what\u2019s of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"npj Vaccin."},{"key":"10.1016\/j.ymthe.2025.09.011_bib4","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.09.011_bib5","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230341","article-title":"Nucleotide modifications enable rational design of TLR7-selective ligands by blocking RNase cleavage","volume":"221","author":"Tong","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib7","article-title":"Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine","author":"Komori","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2025.09.011_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.omtn.2022.11.024","article-title":"Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines","volume":"31","author":"Tregoning","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.09.011_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2015.02.017","article-title":"RIG-I in RNA virus recognition","volume":"479\u2013480","author":"Kell","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2025.09.011_bib10","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.1132998","article-title":"RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates","volume":"314","author":"Pichlmair","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.09.011_bib11","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1093\/nar\/gkw551","article-title":"mRNA capping: biological functions and applications","volume":"44","author":"Ramanathan","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.09.011_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Kariko","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.09.011_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib14","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.15252\/embj.201796476","article-title":"Sensing of viral and endogenous RNA by ZBP1\/DAI induces necroptosis","volume":"36","author":"Maelfait","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2025.09.011_bib15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.omtn.2018.06.010","article-title":"Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification","volume":"12","author":"Vaidyanathan","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.09.011_bib16","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20230372","article-title":"Sensing nucleotide composition in virus RNA","volume":"43","author":"Lo","year":"2023","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ymthe.2025.09.011_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Karik\u00f3","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.09.011_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA","volume":"15","author":"Baiersd\u00f6rfer","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.09.011_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41587-022-01525-6","article-title":"An engineered T7 RNA polymerase that produces mRNA free of immunostimulatory byproducts","volume":"41","author":"Dousis","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102045","article-title":"Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice","volume":"34","author":"Wang","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.09.011_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s42003-023-04555-1","article-title":"Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals","volume":"6","author":"Connors","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.vaccine.2015.10.132","article-title":"A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens","volume":"34","author":"Swaminathan","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.09.011_bib23","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1038\/s41467-024-51411-9","article-title":"Innate immune responses against mRNA vaccine promote cellular immunity through IFN-\u03b2 at the injection site","volume":"15","author":"Kim","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.011_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2311700120","article-title":"Lipid shape and packing are key for optimal design of pH-sensitive mRNA lipid nanoparticles","volume":"121","author":"Tesei","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.09.011_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20636","article-title":"Role of pattern recognition receptors in sensing Mycobacterium tuberculosis","volume":"9","author":"Zihad","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ymthe.2025.09.011_bib26","doi-asserted-by":"crossref","first-page":"24842","DOI":"10.1021\/acsnano.4c05088","article-title":"Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 Axis","volume":"18","author":"Korzun","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2025.09.011_bib27","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.09.011_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: A bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.09.011_bib29","article-title":"Lipid Nanoparticle-Associated Inflammation is Triggered by Sensing of Endosomal Damage: Engineering Endosomal Escape Without Side Effects","author":"Omo-Lamai","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2025.09.011_bib30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib31","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1039\/D2BM00883A","article-title":"mRNA-carrying lipid nanoparticles that induce lysosomal rupture activate NLRP3 inflammasome and reduce mRNA transfection efficiency","volume":"10","author":"Forster Iii","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ymthe.2025.09.011_bib32","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","article-title":"Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques","volume":"25","author":"Liang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/imr.13326","article-title":"Trained immunity: General and emerging concepts","volume":"323","author":"Vuscan","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2025.09.011_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163347","article-title":"Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells","volume":"7","author":"Yamaguchi","year":"2022","journal-title":"JCI insight"},{"key":"10.1016\/j.ymthe.2025.09.011_bib35","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109762","article-title":"The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses","volume":"255","author":"F\u00f6hse","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010830","article-title":"Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion","volume":"18","author":"Qin","year":"2022","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2025.09.011_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1242380","article-title":"BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists","volume":"14","author":"No\u00e9","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.983000","article-title":"mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model","volume":"13","author":"Sittplangkoon","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib40","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.4049\/jimmunol.0802982","article-title":"IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity","volume":"182","author":"Sikora","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib41","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/mt.2016.161","article-title":"Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses","volume":"24","author":"De Beuckelaer","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.omtn.2020.09.004","article-title":"The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration","volume":"22","author":"Van Hoecke","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.09.011_bib43","article-title":"The type I IFN-IL-27 axis promotes mRNA vaccine-induced CD8 (+) T cell responses","author":"Phan","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2025.09.011_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.05.001","article-title":"Type I interferon signaling, regulation and gene stimulation in chronic virus infection","volume":"43","author":"Lukhele","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41541-022-00511-y","article-title":"mRNA vaccines induce rapid antibody responses in mice","volume":"7","author":"Gebre","year":"2022","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2025.09.011_bib46","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41467-022-28517-z","article-title":"Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab","volume":"13","author":"Lin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.011_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102249","article-title":"Neutralising antibody responses against SARS-CoV-2 Omicron BA.4\/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study","volume":"64","author":"Liu","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ymthe.2025.09.011_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-\u03b3, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2025.09.011_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1292568","article-title":"Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations","volume":"14","author":"Rosati","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib50","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114228","article-title":"Waning Immunity after the BNT162b2 Vaccine in Israel","volume":"385","author":"Goldberg","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib51","article-title":"Breakthrough SARS-CoV-2 infections in 620,000 U.S. Veterans, February 1, 2021 to August 13, 2021","author":"Cohn","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.ymthe.2025.09.011_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn8057","article-title":"Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection","volume":"14","author":"Evans","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib53","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1056\/NEJMoa2116597","article-title":"Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants","volume":"386","author":"Eyre","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41591-024-03278-y","article-title":"SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination","volume":"31","author":"Nguyen","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib55","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","article-title":"Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies","volume":"5","author":"Lee","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2024.105464","article-title":"The SARS-CoV-2 antibody-dependent enhancement fa\u00e7ade","volume":"27","author":"Coish","year":"2025","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ymthe.2025.09.011_bib57","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3389\/fimmu.2017.01539","article-title":"Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells","volume":"8","author":"Lindgren","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib58","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib59","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41423-023-01095-w","article-title":"B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity","volume":"21","author":"Lapuente","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.chom.2024.01.010","article-title":"Arming up against Omicron subvariants","volume":"32","author":"Altmann","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2025.09.011_bib61","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1016\/j.cell.2021.10.011","article-title":"Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine","volume":"184","author":"Payne","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.09.011_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.09.011_bib63","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41467-022-28898-1","article-title":"Divergent trajectories of antiviral memory after SARS-CoV-2 infection","volume":"13","author":"Tomic","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.011_bib64","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1038\/s41467-021-27410-5","article-title":"Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England","volume":"12","author":"Amirthalingam","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.011_bib65","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.immuni.2023.03.005","article-title":"Spheromers reveal robust T cell responses to the Pfizer\/BioNTech vaccine and attenuated peripheral CD8(+) T cell responses post SARS-CoV-2 infection","volume":"56","author":"Gao","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.09.011_bib66","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1038\/s41467-023-42433-w","article-title":"Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination","volume":"14","author":"Mitsi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.011_bib67","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41590-023-01562-6","article-title":"mRNA vaccine against malaria tailored for liver-resident memory T cells","volume":"24","author":"Ganley","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib68","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.omtn.2022.10.024","article-title":"cGAMP-adjuvanted multivalent influenza mRNA vaccines induce broadly protective immunity through cutaneous vaccination in mice","volume":"30","author":"Zhu","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.09.011_bib69","doi-asserted-by":"crossref","first-page":"e614","DOI":"10.1016\/S2665-9913(22)00191-6","article-title":"Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study","volume":"4","author":"Simon","year":"2022","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib70","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/s41591-023-02343-2","article-title":"Accelerated waning of the humoral response to COVID-19 vaccines in obesity","volume":"29","author":"van der Klaauw","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib71","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41541-024-01022-8","article-title":"Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity","volume":"9","author":"D\u2019Souza","year":"2024","journal-title":"npj Vaccin."},{"key":"10.1016\/j.ymthe.2025.09.011_bib72","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s43587-024-00644-w","article-title":"Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19","volume":"4","author":"Dallan","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.ymthe.2025.09.011_bib73","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12879-022-07284-8","article-title":"Effect of gender, age and vaccine on reactogenicity and incapacity to work after COVID-19 vaccination: a survey among health care workers","volume":"22","author":"Nachtigall","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.09.011_bib74","first-page":"60","article-title":"Acute inflammatory response to endotoxin in mice and humans","volume":"12","author":"Copeland","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib75","first-page":"71","article-title":"Formulation and Delivery Technologies for mRNA Vaccines","volume":"440","author":"Zeng","year":"2022","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib76","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2015.12.032","article-title":"Materials for non-viral intracellular delivery of messenger RNA therapeutics","volume":"240","author":"Kauffman","year":"2016","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.09.011_bib77","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.2147\/IJN.S168808","article-title":"Main trends of immune effects triggered by nanomedicines in preclinical studies","volume":"13","author":"Halamoda-Kenzaoui","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ymthe.2025.09.011_bib78","article-title":"Lipid nanoparticles in the development of mRNA vaccines for COVID-19","volume":"74","author":"Wilson","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib79","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.09.011_bib80","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib81","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated Blood Clearance and Altered Biodistribution of Repeated Injections of Sterically Stabilized Liposomes1","volume":"292","author":"Dams","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib82","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.xphs.2023.11.001","article-title":"Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives","volume":"113","author":"Gaballa","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ymthe.2025.09.011_bib83","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.drudis.2014.08.015","article-title":"Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics","volume":"19","author":"Verhoef","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ymthe.2025.09.011_bib84","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jconrel.2005.04.003","article-title":"Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes","volume":"105","author":"Ishida","year":"2005","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.09.011_bib85","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2025.09.011_bib86","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.jaip.2021.06.006","article-title":"The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach","volume":"9","author":"Greenhawt","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.ymthe.2025.09.011_bib87","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1016\/j.vaccine.2023.05.029","article-title":"Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination","volume":"41","author":"Zhou","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.09.011_bib88","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/annonc\/mdg374","article-title":"Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil\u00ae): possible role in hypersensitivity reactions","volume":"14","author":"Chanan-Khan","year":"2003","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib89","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.3390\/ijms25073595","article-title":"mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions","volume":"25","author":"Bakos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2025.09.011_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115175","article-title":"The immunostimulatory nature of mRNA lipid nanoparticles","volume":"205","author":"Sharma","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2025.09.011_bib91","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2024.08.016","article-title":"The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNA","volume":"374","author":"Barbieri","year":"2024","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.09.011_bib92","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10213","article-title":"Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles","volume":"6","author":"Schlich","year":"2021","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2025.09.011_bib95","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41541-025-01124-x","article-title":"Ionizable lipid nanoparticles of mRNA vaccines elicit NF-\u03baB and IRF responses through toll-like receptor 4","volume":"10","author":"Zelkoski","year":"2025","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2025.09.011_bib96","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/s41551-024-01256-w","article-title":"Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d","volume":"8","author":"Chaudhary","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2025.09.011_bib97","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ymthe.2024.12.032","article-title":"Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions","volume":"33","author":"Kawai","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib98","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1038\/s41467-022-33157-4","article-title":"Payload distribution and capacity of mRNA lipid nanoparticles","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.011_bib99","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"Petsch","year":"2012","journal-title":"Nat. Biotech."},{"key":"10.1016\/j.ymthe.2025.09.011_bib100","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jconrel.2023.09.001","article-title":"Polyethylenimine (PEI) in gene therapy: Current status and clinical applications","volume":"362","author":"Casper","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.09.011_bib101","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/intimm\/dxu055","article-title":"Polyethyleneimine is a potent systemic adjuvant for glycoprotein antigens","volume":"26","author":"Sheppard","year":"2014","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib102","article-title":"Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium","volume":"31","author":"Patel","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ymthe.2025.09.011_bib103","article-title":"Polymer-Based mRNA Delivery Strategies for Advanced Therapies","volume":"12","author":"Yang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ymthe.2025.09.011_bib104","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1021\/acsnano.0c00326","article-title":"Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer","volume":"14","author":"Blakney","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2025.09.011_bib105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cobme.2018.09.005","article-title":"Polymeric Nucleic Acid Delivery for Immunoengineering","volume":"7","author":"Tzeng","year":"2018","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2025.09.011_bib106","doi-asserted-by":"crossref","first-page":"12315","DOI":"10.1021\/jacs.1c05813","article-title":"One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA","volume":"143","author":"Zhang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2025.09.011_bib107","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/imm.12742","article-title":"Inflammatory responses to influenza vaccination at the extremes of age","volume":"151","author":"McDonald","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.ymthe.2025.09.011_bib108","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/mt.2014.133","article-title":"A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines","volume":"22","author":"Brito","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib109","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.ymthe.2023.06.017","article-title":"A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation","volume":"31","author":"Kimura","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib110","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.ymthe.2023.07.006","article-title":"LION: Taming RNA vaccine inflammation","volume":"31","author":"Tregoning","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1294929","article-title":"Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design","volume":"14","author":"Clemente","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib112","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coviro.2021.03.008","article-title":"Future considerations for the mRNA-lipid nanoparticle vaccine platform","volume":"48","author":"Igy\u00e1rt\u00f3","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib113","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib114","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","article-title":"The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs","volume":"345","author":"LoPresti","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.09.011_bib115","first-page":"12758","article-title":"Impact of Lipid Tail Length on the Organ Selectivity of mRNA-Lipid Nanoparticles","volume":"24","author":"Hashiba","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.ymthe.2025.09.011_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1371596","article-title":"Codon-optimization in gene therapy: promises, prospects and challenges","volume":"12","author":"Paremskaia","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib117","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41434-023-00391-4","article-title":"Terminal hairpins improve protein expression in IRES-initiated mRNA in the absence of a cap and polyadenylated tail","volume":"30","author":"Solodushko","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib118","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-023-06800-3","article-title":"N(1)-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting","volume":"625","author":"Mulroney","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.09.011_bib119","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1473-3099(21)00677-0","article-title":"Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b\/3 trial","volume":"22","author":"Kremsner","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.09.011_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108964","article-title":"Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine","volume":"27","author":"Aboshi","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2025.09.011_bib121","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.ymthe.2024.04.028","article-title":"Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice","volume":"32","author":"Zhou","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib122","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/rmv.360","article-title":"Alphavirus vectors and vaccination","volume":"12","author":"Rayner","year":"2002","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib123","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1126\/science.2922607","article-title":"Sindbis Virus: An Efficient, Broad Host Range Vector for Gene Expression in Animal Cells","volume":"243","author":"Xiong","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.09.011_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105494","article-title":"Targeting the alphavirus virus replication process for antiviral development","volume":"210","author":"Tan","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ymthe.2025.09.011_bib125","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/10548","article-title":"Cancer therapy using a self-replicating RNA vaccine","volume":"5","author":"Ying","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib126","article-title":"A \u2018Sort and Sequence\u2019 Approach to Dissect Heterogeneity of Response to a Self-Amplifying RNA (saRNA) Vector in a Novel Human Muscle Cell Line","volume":"36","author":"Barton","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.09.011_bib127","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41392-023-01561-x","article-title":"Circular RNA vaccine in disease prevention and treatment","volume":"8","author":"Niu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/vaccines9010061","article-title":"Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans","volume":"9","author":"Cagigi","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2025.09.011_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12010059","article-title":"Biodistribution of RNA Vaccines and of Their Products: Evidence from Human and Animal Studies","volume":"12","author":"Pateev","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2025.09.011_bib130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.09.011_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-024-02528-1","article-title":"Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning","author":"Luo","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib132","unstructured":"European Medicines Agency. Assessment Report: Comirnaty, 2021. Amsterdam."},{"key":"10.1016\/j.ymthe.2025.09.011_bib133","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2006.02.013","article-title":"A multiplex branched DNA assay for parallel quantitative gene expression profiling","volume":"352","author":"Flagella","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymthe.2025.09.011_bib134","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib135","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41551-019-0378-3","article-title":"Visualization of early events in mRNA vaccine delivery in non-human primates via PET\u2013CT and near-infrared imaging","volume":"3","author":"Lindsay","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2025.09.011_bib136","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ymthe.2022.01.001","article-title":"A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models","volume":"30","author":"Maruggi","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib137","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.ymthe.2025.09.011_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-023-00785-w","article-title":"Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial","volume":"9","author":"Prins","year":"2024","journal-title":"npj Vaccin."},{"key":"10.1016\/j.ymthe.2025.09.011_bib139","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.ymthe.2025.09.011_bib140","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1002\/adma.201505822","article-title":"Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery","volume":"28","author":"Fenton","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ymthe.2025.09.011_bib141","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/gt.2016.46","article-title":"Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system","volume":"23","author":"DeRosa","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib142","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw6647","article-title":"A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection","volume":"4","author":"Kose","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib143","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ymthe.2019.03.001","article-title":"Improved Efficacy in a Fabry Disease Model Using a Systemic mRNA Liver Depot System as Compared to Enzyme Replacement Therapy","volume":"27","author":"DeRosa","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib144","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.09.011_bib145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/cmi.2015.97","article-title":"Hepatocytes: a key cell type for innate immunity","volume":"13","author":"Zhou","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib146","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nn.2467","article-title":"A robust and high-throughput Cre reporting and characterization system for the whole mouse brain","volume":"13","author":"Madisen","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2025.09.011_bib147","article-title":"A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA Delivery","volume":"10","author":"Naidu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2025.09.011_bib148","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301606120","article-title":"Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination","volume":"120","author":"Ben-Akiva","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.09.011_bib149","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1021\/acs.molpharmaceut.8b00370","article-title":"Monitoring Translation Activity of mRNA-Loaded Nanoparticles in Mice","volume":"15","author":"Rosigkeit","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2025.09.011_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102083","article-title":"mRNA vaccine trafficking and resulting protein expression after intramuscular administration","volume":"35","author":"Hassett","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.09.011_bib151","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1038\/s41467-021-26714-w","article-title":"Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice","volume":"12","author":"Kenjo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.011_bib152","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1021\/acsnano.9b01774","article-title":"The Skin You Are In: Design-of-Experiments Optimization of Lipid Nanoparticle Self-Amplifying RNA Formulations in Human Skin Explants","volume":"13","author":"Blakney","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2025.09.011_bib153","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1021\/acs.biomac.0c00445","article-title":"Mannosylated Poly(ethylene imine) Copolymers Enhance saRNA Uptake and Expression in Human Skin Explants","volume":"21","author":"Blakney","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ymthe.2025.09.011_bib154","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/cid\/ciab465","article-title":"Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients","volume":"74","author":"Ogata","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.09.011_bib155","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","article-title":"Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination","volume":"185","author":"R\u00f6ltgen","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.09.011_bib156","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41541-023-00742-7","article-title":"Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients","volume":"8","author":"Krauson","year":"2023","journal-title":"npj Vaccin."},{"key":"10.1016\/j.ymthe.2025.09.011_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/prca.202300048","article-title":"Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: Possible molecular mechanisms","volume":"17","author":"Brogna","year":"2023","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.ymthe.2025.09.011_bib158","article-title":"Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination","author":"Bhattacharjee","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.ymthe.2025.09.011_bib159","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.2100637","article-title":"Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer\u2013BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines","volume":"207","author":"Bansal","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010255","article-title":"Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responses","volume":"18","author":"Ndeupen","year":"2022","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2025.09.011_bib161","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.omtn.2021.06.008","article-title":"Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA","volume":"25","author":"Aldon","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.09.011_bib162","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-024-00943-2","article-title":"Frameworks for transformational breakthroughs in RNA-based medicines","volume":"23","author":"Androsavich","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.09.011_bib163","author":"Moderna"},{"key":"10.1016\/j.ymthe.2025.09.011_bib164","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1473-3099(23)00650-3","article-title":"Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"24","author":"Oda","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.09.011_bib166","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib167","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41591-024-02955-2","article-title":"An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2\/3 randomized trial","volume":"30","author":"Saraf","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib168","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/infdis\/jiad593","article-title":"Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB\/MF59 Vaccine","volume":"230","author":"Hu","year":"2024","journal-title":"J. Infect Dis."},{"key":"10.1016\/j.ymthe.2025.09.011_bib169","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiae114","article-title":"Safety and Immunogenicity of a Messenger RNA-Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1, Randomized, Clinical Trial","volume":"230","author":"Fierro","year":"2024","journal-title":"J. Infect Dis."},{"key":"10.1016\/j.ymthe.2025.09.011_bib170","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1016\/j.vaccine.2023.05.002","article-title":"Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugate vaccine in adults \u226565 years old","volume":"41","author":"Fitz-Patrick","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.09.011_bib171","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s40121-023-00863-5","article-title":"Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults","volume":"12","author":"Murdoch","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib172","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1038\/s41467-023-39376-7","article-title":"Safety and immunogenicity of a phase 1\/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.011_bib173","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3390\/vaccines11121767","article-title":"A Phase I\/II Clin. Trial Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccin. EXG-5003 against SARS-CoV-2","volume":"11","author":"Koseki","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2025.09.011_bib174","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.redox.2017.03.002","article-title":"Fluorescent proteins such as eGFP lead to catalytic oxidative stress in cells","volume":"12","author":"Ganini","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.ymthe.2025.09.011_bib175","author":"Moderna"},{"key":"10.1016\/j.ymthe.2025.09.011_bib176","doi-asserted-by":"crossref","first-page":"eadg1036","DOI":"10.1126\/sciadv.adg1036","article-title":"A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium","volume":"9","author":"Kon","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2025.09.011_bib177","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.vaccine.2016.11.040","article-title":"Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens","volume":"35","author":"Maruggi","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.09.011_bib178","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41541-025-01202-0","article-title":"Intranasal delivery of mRNA expressing newly identified Acinetobacter baumannii antigens protects against bacterial lung disease","volume":"10","author":"Higham","year":"2025","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2025.09.011_bib179","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41541-023-00672-4","article-title":"Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa","volume":"8","author":"Wang","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2025.09.011_bib180","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.ymthe.2024.06.031","article-title":"The tricky second album: Licensure of an mRNA vaccine for respiratory syncytial virus","volume":"32","author":"Tregoning","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib181","author":"Moderna"},{"key":"10.1016\/j.ymthe.2025.09.011_bib182","doi-asserted-by":"crossref","first-page":"e637","DOI":"10.1093\/infdis\/jiae035","article-title":"Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial","volume":"230","author":"Shaw","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.09.011_bib183","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.abm0271","article-title":"A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes","volume":"378","author":"Arevalo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.09.011_bib184","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-amplifying RNA vaccines for infectious diseases","volume":"28","author":"Bloom","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.011_bib185","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1473-3099(24)00060-4","article-title":"Persistence of immune responses of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2","volume":"24","author":"Oda","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.09.011_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101262","article-title":"Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial","volume":"44","author":"Pollock","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ymthe.2025.09.011_bib187","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1038\/s41467-023-39053-9","article-title":"GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for \u22656 months in previously-vaccinated older adults","volume":"14","author":"Palmer","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.011_bib188","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010885","article-title":"Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines","volume":"18","author":"Elliott","year":"2022","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2025.09.011_bib189","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/14760584.2022.2098719","article-title":"Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis","volume":"21","author":"Sutton","year":"2022","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.ymthe.2025.09.011_bib190","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1038\/s41467-024-50376-z","article-title":"Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases","volume":"15","author":"Baden","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.09.011_bib191","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae051","article-title":"Real-world Effectiveness of mRNA COVID-19 Vaccines Among US Nursing Home Residents Aged \u226565 Years in the Pre-Delta and High Delta Periods","volume":"11","author":"Lu","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.09.011_bib192","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s12276-023-00999-x","article-title":"Knife\u2019s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.09.011_bib193","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00915-21","article-title":"Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines","volume":"7","author":"Zhang","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.ymthe.2025.09.011_bib194","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9101089","article-title":"Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2","volume":"9","author":"Bauernfeind","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2025.09.011_bib195","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2315659","article-title":"Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data","volume":"20","author":"van den Ouweland","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2025.09.011_bib196","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","article-title":"COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals","volume":"42","author":"Faksova","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.09.011_bib197","article-title":"Post-Vaccination Syndrome: A Descriptive Analysis of Reported Symptoms and Patient Experiences After Covid-19 Immunization","author":"Krumholz","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.ymthe.2025.09.011_bib198","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/archdischild-2024-328109","article-title":"Glycerol intoxication syndrome in young children, following the consumption of slush ice drinks","volume":"110","author":"Brothwell","year":"2025","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymthe.2025.09.011_bib199","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1426129","article-title":"Understanding the impact of in vitro transcription byproducts and contaminants","volume":"11","author":"Lenk","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymthe.2025.09.011_bib200","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/mps7030041","article-title":"Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty\u00ae","volume":"7","author":"K\u00f6nig","year":"2024","journal-title":"Methods Protoc."},{"key":"10.1016\/j.ymthe.2025.09.011_bib201","article-title":"Quantification of Objective Concentrations of DNA Impurities in mRNA Vaccines","volume":"55","author":"Kaiser","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2025.09.011_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102489","article-title":"mRNA-1273 is placenta-permeable and immunogenic in the fetus","volume":"36","author":"Chen","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.09.011_bib204","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1016\/j.vaccine.2023.03.038","article-title":"Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis","volume":"41","author":"Ciapponi","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.09.011_bib205","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3390\/vaccines11091456","article-title":"Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis","volume":"11","author":"Widhani","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2025.09.011_bib206","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(17)31665-3","article-title":"Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial","volume":"390","author":"Alberer","year":"2017","journal-title":"Lancet"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625007397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625007397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:57:41Z","timestamp":1766152661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625007397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":205,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1525001625007397"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.09.011","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunology of RNA-based vaccines: The critical interplay between inflammation and expression","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}